• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA TYMP1 通过 microRNA-182A-3p/TGFβ1 轴减少 Smad2/3 磷酸化抑制卵巢癌细胞发生和顺铂耐药性。

Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.

机构信息

Department of Gynecological Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin 300100, China.

Research Institute of Obstetrics and Gynecology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin 300100, China.

出版信息

Contrast Media Mol Imaging. 2022 Aug 16;2022:1032557. doi: 10.1155/2022/1032557. eCollection 2022.

DOI:10.1155/2022/1032557
PMID:36072623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9398837/
Abstract

TYMP1 is a cancer driver in several human malignancies. However, its significance in ovarian cancer (ovarian carcinoma) remains uncertain. This research aims to understand the TYMP1's role in ovarian carcinoma carcinogenesis and cisplatin (DDP) resistance and its molecular ovarian marchionesses. Circ TYMP1 overexpression in ovarian carcinoma samples led to an accelerated tumor stage. Bioinformatics identified miR-182A-3p as the TYMP1's target transcript. Circ TYMP1 functioned as a sponge for miR-182A-3p, lowering its inhibitory effect on TGF1B. Downregulating circ TYMP1 decreased A2780-Res cell proliferation, invasion, and death resistance. Malignant ovarian carcinoma cells recovered following miR-182A-3p downregulation. TGF1B overexpression boosted A2780-Res cell proliferation, aggression, and cisplatin resistance while reducing Smad2/3 phosphorylation. TYMP1 sequesters miR-182A-3p and promotes TGF1B in ovarian carcinoma, boosting carcinogenesis and cisplatin resistance. This might lead to novel ovarian carcinoma treatments.

摘要

TYMP1 是几种人类恶性肿瘤的致癌驱动因子。然而,其在卵巢癌(卵巢癌)中的意义尚不确定。本研究旨在了解 TYMP1 在卵巢癌发生和顺铂(DDP)耐药中的作用及其分子机制。卵巢癌样本中 TYMP1 的circRNA 过表达导致肿瘤分期加速。生物信息学鉴定出 miR-182A-3p 是 TYMP1 的靶转录本。circTYMP1 作为 miR-182A-3p 的海绵,降低了其对 TGF1B 的抑制作用。下调 circTYMP1 可降低 A2780-Res 细胞的增殖、侵袭和耐药性。下调 miR-182A-3p 后,恶性卵巢癌细胞恢复生长。TGF1B 过表达可促进 A2780-Res 细胞的增殖、侵袭和对顺铂的耐药性,同时降低 Smad2/3 磷酸化。TYMP1 可与 miR-182A-3p 结合并促进卵巢癌中的 TGF1B,从而促进肿瘤发生和顺铂耐药。这可能为卵巢癌的治疗提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/9398837/2d0cc1d4aa9e/CMMI2022-1032557.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/9398837/2d0cc1d4aa9e/CMMI2022-1032557.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/9398837/2d0cc1d4aa9e/CMMI2022-1032557.002.jpg

相似文献

1
Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.环状 RNA TYMP1 通过 microRNA-182A-3p/TGFβ1 轴减少 Smad2/3 磷酸化抑制卵巢癌细胞发生和顺铂耐药性。
Contrast Media Mol Imaging. 2022 Aug 16;2022:1032557. doi: 10.1155/2022/1032557. eCollection 2022.
2
Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer.环状 RNA 0067934 通过 microRNA-545-3p/PPA1 轴减少 JNK 磷酸化,从而增强卵巢癌细胞的致瘤性和顺铂耐药性。
Immunopharmacol Immunotoxicol. 2022 Apr;44(2):261-274. doi: 10.1080/08923973.2022.2038193. Epub 2022 Feb 18.
3
Retracted: Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.撤回:环状TYMP1通过MicroRNA-182A-3p/TGF1B轴减少Smad2/3磷酸化来抑制卵巢癌的发生和顺铂耐药性。
Contrast Media Mol Imaging. 2023 Aug 9;2023:9765812. doi: 10.1155/2023/9765812. eCollection 2023.
4
circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.环状 CSPP1 通过作为 miR-1236-3p 的海绵吸附子促进卵巢癌细胞的增殖、侵袭和迁移。
Biomed Pharmacother. 2019 Jun;114:108832. doi: 10.1016/j.biopha.2019.108832. Epub 2019 Apr 11.
5
Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.Circ_0026123通过隔离miR-543上调RAB1A,从而促进卵巢癌顺铂耐药性及进展。
Anticancer Drugs. 2022 Nov 1;33(10):1069-1080. doi: 10.1097/CAD.0000000000001373. Epub 2022 Sep 29.
6
miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.miR-29c-3p 通过调控 FOXP1/ATG14 通路抑制卵巢癌细胞自噬和顺铂耐药。
Cell Cycle. 2020 Jan;19(2):193-206. doi: 10.1080/15384101.2019.1704537. Epub 2019 Dec 29.
7
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.环状 RNA(circRNA)-PGAM1 通过调控 miR-542-3p/CDC5L/PEAK1 通路促进上皮性卵巢癌的恶性进展。
Cancer Med. 2020 May;9(10):3500-3521. doi: 10.1002/cam4.2929. Epub 2020 Mar 13.
8
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.RNA 结合蛋白 IGF2BP2 通过 microRNA-3187-3p/ERBB4/PI3K/AKT 轴增强卵巢癌细胞中 circ_0000745 的丰度,并促进其侵袭性和干性。
J Ovarian Res. 2021 Nov 13;14(1):154. doi: 10.1186/s13048-021-00917-7.
9
Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).Circ_0020123 通过海绵吸附 miR-140-3p 调控同源盒 B5(HOXB5)从而部分增强非小细胞肺癌细胞对顺铂的耐药性。
Bioengineered. 2022 Mar;13(3):5126-5140. doi: 10.1080/21655979.2022.2036910.
10
circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.circ_0007385 作为竞争性内源性 RNA,与 miR-519d-3p 结合,抑制非小细胞肺癌细胞的恶性行为和顺铂耐药性。
Thorac Cancer. 2020 Aug;11(8):2196-2208. doi: 10.1111/1759-7714.13527. Epub 2020 Jun 29.

引用本文的文献

1
Molecular mechanisms of cisplatin resistance in ovarian cancer.卵巢癌中顺铂耐药的分子机制。
Genes Dis. 2023 Aug 2;11(6):101063. doi: 10.1016/j.gendis.2023.06.032. eCollection 2024 Nov.
2
Retracted: Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.撤回:环状TYMP1通过MicroRNA-182A-3p/TGF1B轴减少Smad2/3磷酸化来抑制卵巢癌的发生和顺铂耐药性。
Contrast Media Mol Imaging. 2023 Aug 9;2023:9765812. doi: 10.1155/2023/9765812. eCollection 2023.
3
"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.

本文引用的文献

1
MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway.微小RNA-140通过沉默调节蛋白1/活性氧/应激活化蛋白激酶途径使顺铂耐药的非小细胞肺癌细胞对顺铂治疗重新敏感。
Onco Targets Ther. 2020 Aug 17;13:8149-8160. doi: 10.2147/OTT.S261799. eCollection 2020.
2
Circular RNA circ_0067934 functions as an oncogene in breast cancer by targeting Mcl-1.环状RNA circ_0067934通过靶向Mcl-1在乳腺癌中发挥癌基因作用。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7214. doi: 10.26355/eurrev_202007_21865.
3
Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis.
“DEPHENCE”系统——一种高级别浆液性卵巢癌迫切需要的新型治疗方案——聚焦于抗癌干细胞和抗肿瘤微环境靶向治疗。
Front Oncol. 2023 Jun 28;13:1201497. doi: 10.3389/fonc.2023.1201497. eCollection 2023.
4
Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance.妇科癌症中的环状RNA:化疗耐药机制及其影响
Front Pharmacol. 2023 Jun 8;14:1194719. doi: 10.3389/fphar.2023.1194719. eCollection 2023.
Circ_0072083干扰通过miR-545-3p/CBLL1轴增强顺铂对非小细胞肺癌细胞的生长抑制作用。
Cancer Cell Int. 2020 Mar 12;20:78. doi: 10.1186/s12935-020-1162-x. eCollection 2020.
4
RNA: interactions drive functionalities.RNA:相互作用驱动功能。
Mol Biol Rep. 2020 Feb;47(2):1413-1434. doi: 10.1007/s11033-019-05230-7. Epub 2019 Dec 14.
5
"I am not a statistic" ovarian cancer survivors' views of factors that influenced their long-term survival.“我不是一个数字”——卵巢癌幸存者对影响其长期生存因素的看法。
Gynecol Oncol. 2019 Dec;155(3):461-467. doi: 10.1016/j.ygyno.2019.10.007. Epub 2019 Nov 6.
6
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.顺铂直接作用于线粒体诱导活性氧的产生,决定卵巢癌细胞的命运。
Cell Death Dis. 2019 Nov 7;10(11):851. doi: 10.1038/s41419-019-2081-4.
7
PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner.PPA1通过JNK和TP53依赖的方式促进非小细胞肺癌进展。
Oncogenesis. 2019 Sep 24;8(10):53. doi: 10.1038/s41389-019-0162-y.
8
Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis.环状 RNA(hsa_circ_0051240)通过 miR-637/KLK4 轴促进卵巢癌细胞的增殖、迁移和侵袭。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1224-1233. doi: 10.1080/21691401.2019.1593999.
9
Therapeutic efficacy and safety of radiofrequency ablation for the treatment of trigeminal neuralgia: a systematic review and meta-analysis.射频消融治疗三叉神经痛的疗效与安全性:一项系统评价与Meta分析
J Pain Res. 2019 Jan 18;12:423-441. doi: 10.2147/JPR.S176960. eCollection 2019.
10
Ovarian cancer stem cells and their role in drug resistance.卵巢癌细胞及其在耐药性中的作用。
Int J Biochem Cell Biol. 2019 Jan;106:117-126. doi: 10.1016/j.biocel.2018.11.012. Epub 2018 Nov 30.